Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Laparoscopic Subtotal Hysterectomy Found Effective for Menorrhagia

By HospiMedica staff writers
Posted on 20 May 2008
Laparoscopic subtotal hysterectomy (LSH) is safe and effective treatment for menorrhagia, according to a new study. More...


Researchers of the Princess Royal University Hospital (Orpington, United Kingdom) conducted a prospective observational study and investigated the outcomes (including complication rates and patient acceptability) of 400 consecutive LSHs for menorrhagia resistant to medical treatment (96%), dysfunctional uterine bleeding not responding to hormonal treatment, known symptomatic myomas, or failed previous endometrial ablation. The mean duration of surgery was 46.4 minutes and the mean operative blood loss was 126 ml. Three quarters of the procedures were performed as day cases.

The study results showed that three women (0.75%) sustained bladder entry that was repaired laparoscopically and two (0.5%) incurred bowel injury, and only 7 women (1.7%) developed postoperative infections. There were no postoperative transfusions or returns to the operating theater because of excessive blood loss. Five women ultimately required laparoscopic removal of the cervix because of persistent cyclical vaginal bleeding after the procedure. Women returned to work after an average of two weeks, and most women resumed sexual activity 3 to 4 weeks after surgery; 98% of the women reported satisfaction with the operation and would recommend the procedure to a friend. The study was published in the May 2008 issue of the British Journal of Obstetrics and Gynaecology (BJOG).

"LSH is a safe and effective treatment for menorrhagia and other menstrual disorders when hysterectomy is indicated,” concluded John Erian, M.D., and colleagues of the department of obstetrics and gynecology. "Women appreciate the quick recovery period, reduced time off work and faster return to normal activity. Our data suggest that LSH can replace abdominal hysterectomy in selected cases.”

Menorrhagia (also known as hypermenorrhea) is an abnormally heavy and prolonged menstrual period at regular intervals. Causes may be due to abnormal blood clotting, disruption of normal hormonal regulation of periods, or disorders of the endometrial lining of the uterus. If a normal menstrual cycle is 21-35 days in duration, with bleeding lasting an average of 5 days and total blood flow between 25 and 80 ml, a blood loss of greater than 80 ml or lasting longer than 7 days constitutes menorrhagia. Treatment options include pharmaceutical or surgical and radiological options.


Related Links:
Princess Royal University Hospital

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.